Evidence map›Paper›PMID 36234852›Full record

ReviewMolecules (Basel, Switzerland)2022

New Insights into Dietary Pterostilbene: Sources, Metabolism, and Health Promotion Effects.

Sanjushree Nagarajan, Sundhar Mohandas, Kumar Ganesan, Baojun Xu, Kunka Mohanram Ramkumar

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Pterostilbene-mediated microbiota shifts: Implications and opportunities.Journal of traditional and complementary medicine · 2026
    Review
  10. Article
  11. Review
  12. Antifungal Effects of Pterostilbene onJournal of fungi (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Article
  15. Pterostilbene as a promising natural anticancer agent in gynecological cancers.Medical oncology (Northwood, London, England) · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Sanjushree NagarajanDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science & Technology, Kattankulathur 603 203, India.ORCID 0000-0003-3759-9283
Sundhar MohandasDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science & Technology, Kattankulathur 603 203, India.
Kumar GanesanSchool of Chinese Medicine, LKS Faculty of Medicine, University of Hong Kong, 10 Sassoon Road, Hong Kong 999077, China.ORCID 0000-0002-3198-6066
Baojun XuFood Science and Technology Programme, Department of Life Sciences, BNU-HKBU United International College, Zhuhai 519087, China.ORCID 0000-0003-0739-3735
Kunka Mohanram RamkumarDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science & Technology, Kattankulathur 603 203, India.
SRM Institute of Science and Technology · INBeijing Normal-Hong Kong Baptist University · CNChinese University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pterostilbene (PTS), a compound most abundantly found in blueberries, is a natural analog of resveratrol. Several plant species, such as peanuts and grapes, produce PTS. While resveratrol has been extensively studied for its antioxidant properties, recent evidence also points out the diverse therapeutic potential of PTS. Several studies have identified the robust pharmacodynamic features of PTS, including better intestinal absorption and elevated hepatic stability than resveratrol. Indeed, due to its higher bioavailability paired with reduced toxicity compared to other stilbenes, PTS has become an attractive drug candidate for the treatment of several disease conditions, including diabetes, cancer, cardiovascular disease, neurodegenerative disorders, and aging. This review article provides an extensive summary of the nutraceutical potential of PTS in various disease conditions while discussing the crucial mechanistic pathways implicated. In particular, we share insights from our studies about the Nrf2-mediated effect of PTS in diabetes and associated complications. Moreover, we elucidate the important sources of PTS and discuss in detail its pharmacokinetics and the range of formulations and routes of administration used across experimental studies and human clinical trials. Furthermore, this review also summarizes the strategies successfully used to improve dietary availability and the bio-accessibility of PTS.

Indexed as

NF-E2-Related Factor 2StilbenesAntioxidantsHealth PromotionHumansResveratrol3,5-dimethoxy-4'-hydroxystilbeneAntioxidantsNF-E2-Related Factor 2pterostilbeneResveratrolStilbenesantioxidantbioavailabilitycancerdiabetesNrf2pterostilbeneresveratrol

Identifiers

PMID36234852
PMCPMC9571692
OpenAlexW4297229376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.